295 related articles for article (PubMed ID: 17320652)
1. Role of pelvic lymphadenectomy in prostate cancer management.
Sivalingam S; Oxley J; Probert JL; Stolzenburg JU; Schwaibold H
Urology; 2007 Feb; 69(2):203-9. PubMed ID: 17320652
[No Abstract] [Full Text] [Related]
2. Role of lymphadenectomy for prostate cancer: indications and controversies.
La Rochelle JC; Amling CL
Urol Clin North Am; 2011 Nov; 38(4):387-95, v. PubMed ID: 22045170
[TBL] [Abstract][Full Text] [Related]
3. Long-term follow-up of patients with prostate cancer and nodal metastases treated by pelvic lymphadenectomy and radical prostatectomy: the positive impact of adjuvant radiotherapy.
Da Pozzo LF; Cozzarini C; Briganti A; Suardi N; Salonia A; Bertini R; Gallina A; Bianchi M; Fantini GV; Bolognesi A; Fazio F; Montorsi F; Rigatti P
Eur Urol; 2009 May; 55(5):1003-11. PubMed ID: 19211184
[TBL] [Abstract][Full Text] [Related]
4. Percentage of positive biopsies predicts lymph node involvement in men with low-risk prostate cancer undergoing radical prostatectomy and extended pelvic lymphadenectomy.
Heidenreich A; Pfister D; Thüer D; Brehmer B
BJU Int; 2011 Jan; 107(2):220-5. PubMed ID: 20590538
[TBL] [Abstract][Full Text] [Related]
5. Is radiotherapy useful in node-positive prostate cancer patients after radical prostatectomy?
Van Poppel H
Eur Urol; 2009 May; 55(5):1012-3. PubMed ID: 19261377
[No Abstract] [Full Text] [Related]
6. Lymph node assessment and lymphadenectomy in prostate cancer.
Ordon M; Nam RK
J Surg Oncol; 2009 Mar; 99(4):215-24. PubMed ID: 19170044
[TBL] [Abstract][Full Text] [Related]
7. Prostatic biopsy undergrading: the feasibility of secondary laparoscopic pelvic lymphadenectomy.
Hellawell G; Ramírez-Backhaus M; Rabenalt R; Do M; Dietel A; Stolzenburg JU
Urol Int; 2010; 85(2):139-42. PubMed ID: 20516675
[TBL] [Abstract][Full Text] [Related]
8. Sentinel lymph node dissection for prostate cancer: experience with more than 1,000 patients.
Weckermann D; Dorn R; Trefz M; Wagner T; Wawroschek F; Harzmann R
J Urol; 2007 Mar; 177(3):916-20. PubMed ID: 17296375
[TBL] [Abstract][Full Text] [Related]
9. Re: Prognosis of patients with lymph node positive prostate cancer following radical prostatectomy: long-term results.
Maffezzini M
J Urol; 2005 Sep; 174(3):1151-2; author reply 1152. PubMed ID: 16094087
[No Abstract] [Full Text] [Related]
10. Histopathological characteristics of lymph node metastases predict cancer-specific survival in node-positive prostate cancer.
Boormans JL; Wildhagen MF; Bangma CH; Verhagen PC; van Leenders GJ
BJU Int; 2008 Dec; 102(11):1589-93. PubMed ID: 18710447
[TBL] [Abstract][Full Text] [Related]
11. Feasibility of minimally invasive lymphadenectomy in bladder and prostate cancer surgery.
Hakimi AA; Ghavamian R
Urol Clin North Am; 2011 Nov; 38(4):407-18, v. PubMed ID: 22045172
[TBL] [Abstract][Full Text] [Related]
12. Long-term outcome after radical prostatectomy for patients with lymph node positive prostate cancer in the prostate specific antigen era.
Boorjian SA; Thompson RH; Siddiqui S; Bagniewski S; Bergstralh EJ; Karnes RJ; Frank I; Blute ML
J Urol; 2007 Sep; 178(3 Pt 1):864-70; discussion 870-1. PubMed ID: 17631342
[TBL] [Abstract][Full Text] [Related]
13. The role of pelvic lymphadenectomy for prostate cancer--therapeutic?
Wagner M; Sokoloff M; Daneshmand S
J Urol; 2008 Feb; 179(2):408-13. PubMed ID: 18076938
[TBL] [Abstract][Full Text] [Related]
14. Does the molecular staging in pelvic lymph nodes improve the detection of relevant prostate cancer metastases? An assessment after 6 years.
Schostak M; Krause H; Miller K; Schrader M; Kempkensteffen C; Kollermann J
BJU Int; 2007 Jun; 99(6):1409-14. PubMed ID: 17428244
[TBL] [Abstract][Full Text] [Related]
15. Anatomical extent of pelvic lymphadenectomy in patients undergoing radical prostatectomy.
Heidenreich A; Ohlmann CH; Polyakov S
Eur Urol; 2007 Jul; 52(1):29-37. PubMed ID: 17448592
[TBL] [Abstract][Full Text] [Related]
16. Radioisotope guided sentinel lymph node dissection in patients with localized prostate cancer: results of the first 100 cases.
Bastide C; Brenot-Rossi I; Garcia S; Rossi D
Eur J Surg Oncol; 2009 Jul; 35(7):751-6. PubMed ID: 18538526
[TBL] [Abstract][Full Text] [Related]
17. Clinical importance of lymph node density in predicting outcome of prostate cancer patients.
Cai T; Nesi G; Tinacci G; Giubilei G; Gavazzi A; Mondaini N; Zini E; Bartoletti R
J Surg Res; 2011 May; 167(2):267-72. PubMed ID: 19783007
[TBL] [Abstract][Full Text] [Related]
18. [Pro and contra pelvic lymphadenectomy in prostatic carcinoma].
Heidenreich A
Aktuelle Urol; 2004 Feb; 35(1):28-32. PubMed ID: 15046024
[No Abstract] [Full Text] [Related]
19. [The role of laparoscopy in the management of prostatic cancer].
Haas GP; Shumaker BP; Haas PA; Tóth C
Orv Hetil; 1995 Sep; 136(37):2005-7. PubMed ID: 7566932
[TBL] [Abstract][Full Text] [Related]
20. Lymphadenectomy in the surgical management of penile cancer.
Protzel C; Alcaraz A; Horenblas S; Pizzocaro G; Zlotta A; Hakenberg OW
Eur Urol; 2009 May; 55(5):1075-88. PubMed ID: 19264390
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
